Infliximab monograph adopted by European Pharmacopoeia Commission

By Gareth Macdonald contact

- Last updated on GMT

Gettyimages/ultramarine5
Gettyimages/ultramarine5

Related tags: Monoclonal antibodies, European pharmacopoeia, European directorate for the quality of medicines

European Pharmacopoeia Commission has adopted the first monograph for a monoclonal antibody and is poised to add it to the European Pharmacopoeia.

The Commission adopted the “Infliximab concentrated solution” monograph last month​ according to the European Directorate for the Quality of Medicines & HealthCare (EDQM), which said it marked the end of several years of development. 

The Ph. Eur. Commission embarked upon the setting of public standards for therapeutic monoclonal antibodies (mAbs) in 2014 with a pilot phase and following extensive consultation with its stakeholders​.”

The EDQM added that the collaborative approach was required to give the monograph the flexibility needed to accommodate the process-dependent heterogeneity associated with mAbs and their production.

 “The approach used to set the monograph specifications is oriented towards promoting flexibility, notably in addressing process-dependent product heterogeneity.

Significantly, criteria for verifying the performance of analytical methods are included, which will support robust methodologies, while the provision of examples of suitable procedures for complex assays enables the use of alternative methods​,” the directorate said.

The newly adopted infliximab monograph will be included in Pharmacopoeia Supplement 9.6 and will become effective in January 2019.

Related news

Show more

Related products

show more

Nifty Biosimilar

Nifty Biosimilar

UGA Biopharma | 13-Mar-2018 | Research Study

Aflibercept (Zaltrap®) is a recombinant fusion protein with complex post-translational modifications. Therefore deep understanding of biosimilar development...

Featured eBook: Complex Protein Production

Featured eBook: Complex Protein Production

Catalent Pharma Solutions | 06-Mar-2018 | Technical / White Paper

Download the eBook written by Catalent experts to learn about innovative products and techniques for scale-up of complex biologics, get optimal cell culture...

biopharma-reporter-image

Inline diafiltration enables continuous processing

Pall Life Sciences | 13-Feb-2018 | Application Note

The Cadence inline diafiltration (ILDF) device is designed for continuous processing, in-process buffer exchange or contaminant removal in various processes...

Related suppliers